Subscription Center
Cross-posted from Nature Medicine‘s Spoonful of Medicine blog
Results from two trials released today provide the first evidence that taking antiretroviral drugs can prevent HIV infection among heterosexual men and women.
The preventative strategy, known as pre-exposure prophylaxis (PrEP), was first shown to be effective among gay men. But PrEP suffered a setback in April when a study testing the drug Truvada among women in Africa had to be halted prematurely owing to lack of efficacy. The new trial data, however, shows that the approach has broad potential in the quest to prevent HIV transmission, according to experts in the field.
“This is the first strong, compelling evidence that PrEP can work in this population,” said Kevin Fenton, director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at the US Centers for Disease Control and Prevention (CDC), during a press briefing earlier today. “It’s a major milestone.”
Continue reading on Nature Medicine‘s blog >>
What Rational Really Means
Is It Quantum Computing or Not?
Bush-crow diaries: Settling in with the Borana
Is Homosexuality Natural? Yes. So is male lactation.
Why Barns Are Red, and More - The Countdown, Episode 22 
Bora's Picks (May 17th, 2013)
See what we're tweeting about
David_Bressan GOOOOD MORNING, Washington, the weather today: sunny with imminent volcanic eruption
Dhunterauthor Cis people: Help me get a sense of the landscape out there!: http://t.co/7X5j84STGa
BoraZ Oh, Spring http://t.co/A8B86eYATp
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
Share
Email
Print
Add a Comment
You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.